Middle meningeal artery embolization with subdural evacuating port system for primary management of chronic subdural hematomas

• Published in: Neurosurgical review Vol. 45; no. 1; pp. 439 - 449
• Main Authors: Carpenter, Austin, Rock, Mitchell, Dowlati, Ehsan, Miller, Charles, Mai, Jeffrey C., Liu, Ai-Hsi, Armonda, Rocco A., Felbaum, Daniel R.
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.02.2022
• Subjects: Embolization, Therapeutic; Hematoma, Subdural, Chronic - surgery; Humans; Medicine; Medicine & Public Health; Meningeal Arteries; Neurosurgery; Original Article; Retrospective Studies; Subdural Space; Embolization; Craniostomy; SEPS; Subdural hematoma; Middle meningeal artery
• ISSN: 0344-5607; 1437-2320
• DOI: 10.1007/s10143-021-01553-x

Optimal treatment for chronic subdural hematomas remains controversial and perioperative risks and comorbidities may affect management strategies. Minimally invasive procedures are emerging as alternatives to the standard operative treatments. We evaluate our experience with middle meningeal artery (MMA) embolization combined with Subdural Evacuating Port System (SEPS) placement as a first-line treatment for patients with cSDH. A single institution retrospective review was performed of all patients undergoing intervention. Patients were stratified by treatment with MMA embolization and SEPS placement, MMA embolization and surgery, SEPS placement only, and surgery only for cSDH from 2017 to 2020, and cohorts were compared against each other. Patients treated with MMA/SEPS were more likely to be older, be on anticoagulation, have significant comorbidities, have shorter length of stay, and less likely to have symptomatic recurrence compared to SEPS only cohort. Thus, MMA/SEPS appears to be a safe and equally effective minimally invasive treatment for cSDH patients with significant comorbidities who are poor surgical candidates.